Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline (vol 41, pg 1470, 2023)

被引：0
|
作者：
Uboha, Nataliya V.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 13期
关键词：
D O I：
10.1200/JCO.23.00441
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2454 / 2454
页数：1
相关论文
共 50 条
  • [41] Adjuvant immunotherapy and targeted therapy in early and locally advanced resectable lung cancer: expanding treatment tentacles?
    Fergadis, Evaggelos
    Heitmann, Amadea
    Tsaras, Theodore
    Hardavella, Georgia
    BREATHE, 2024, 20 (02)
  • [42] Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real world
    Shokoohi, Aria
    Al-Hashami, Zamzam
    Moore, Sara
    Pender, Alexandra
    Wong, Selina K.
    Wang, Ying
    Leung, Bonnie
    Wu, Jonn
    Ho, Cheryl
    CANCER MEDICINE, 2022, 11 (01): : 86 - 93
  • [43] Neoadjuvant therapy for locally advanced breast cancer: focus on chemotherapy and biological targeted treatments' armamentarium (vol 2, pg 160, 2010)
    Papademetriou, Konstantinos
    JOURNAL OF THORACIC DISEASE, 2013, 5 (04) : E181 - E181
  • [44] Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250) (vol 41, pg 4154, 2023)
    Ingham, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (33) : 5205 - 5205
  • [45] Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion (vol 40, pg 1231, 2022)
    Chakravarty, Debyani
    Johnson, Amber
    Sklar, Jeffrey
    Lindeman, Neal I.
    Moore, Kathleen
    Ganesan, Shridar
    Lovly, Christine M.
    Perlmutter, Jane
    Gray, Stacy W.
    Hwang, Jimmy
    Lieu, Christopher
    Andre, Fabrice
    Azad, Nilofer
    Borad, Mitesh
    Tafe, Laura
    Messersmith, Hans
    Robson, Mark
    Meric-Bernstam, Funda
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (18) : 2068 - 2068
  • [46] Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-CDK4/6 Inhibitors: ASCO Rapid Guideline Update Clinical Insights
    Caswell-Jin, Jennifer L.
    Freedman, Rachel A.
    Hassett, Michael J.
    Tang, Hao
    Garrett-Mayer, Elizabeth
    Somerfield, Mark R.
    Giordano, Sharon H.
    JCO ONCOLOGY PRACTICE, 2025, 21 (03)
  • [47] The ASCO/CAP guideline update for HER2 testing increases the number of breast cancer patients eligible for HER2-targeted therapy
    Giacomazzi, Juliana
    Hartmann, Carolina R.
    Paskulin, Diego D.
    Rivero, Luis Fernando
    Caleffi, Maira
    Pasqualotto, Alessandro C.
    Graudenz, Marcia S.
    Rosa, Daniela D.
    CANCER RESEARCH, 2015, 75
  • [48] 2006 Update of ASCO Practice Guideline for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: Guideline Summary (Vol 2, pg 175, 2007)
    Oratz, R.
    JOURNAL OF ONCOLOGY PRACTICE, 2007, 3 (05) : 287 - 287
  • [49] Efficacy and clinical monitoring strategies for immune checkpoint inhibitors and targeted cytokine immunotherapy for locally advanced and metastatic colorectal cancer (vol 49, pg 1, 2019)
    Bess, Shelby N.
    Greening, Gage J.
    Muldoon, Timothy J.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 55 : 119 - 119
  • [50] Camptothecin-based prodrug nanomedicines for cancer therapy (vol 15, pg 17658, 2023)
    Zhang, Renshuai
    Yu, Jing
    Guo, Zhu
    Jiang, Hongfei
    Wang, Chao
    NANOSCALE, 2025, 17 (05) : 2912 - 2912
12345